Baillie George S, Adams David R, Bhari Narinder, Houslay Thomas M, Vadrevu Suryakiran, Meng Dong, Li Xiang, Dunlop Allan, Milligan Graeme, Bolger Graeme B, Klussmann Enno, Houslay Miles D
Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow G12 8QQ, Scotland, UK.
Biochem J. 2007 May 15;404(1):71-80. doi: 10.1042/BJ20070005.
Beta2-ARs (beta2-adrenoceptors) become desensitized rapidly upon recruitment of cytosolic beta-arrestin. PDE4D5 (family 4 cAMP-specific phosphodiesterase, subfamily D, isoform 5) can be recruited in complex with beta-arrestin, whereupon it regulates PKA (cAMP-dependent protein kinase) phosphorylation of the beta2-AR. In the present study, we have used novel technology, employing a library of overlapping peptides (25-mers) immobilized on cellulose membranes that scan the entire sequence of beta-arrestin 2, to define the interaction sites on beta-arrestin 2 for binding of PDE4D5 and the cognate long isoform, PDE4D3. We have identified a binding site in the beta-arrestin 2 N-domain for the common PDE4D catalytic unit and two regions in the beta-arrestin 2 C-domain that confer specificity for PDE4D5 binding. Alanine-scanning peptide array analysis of the N-domain binding region identified severely reduced interaction with PDE4D5 upon R26A substitution, and reduced interaction upon either K18A or T20A substitution. Similar analysis of the beta-arrestin 2 C-domain identified Arg286 and Asp291, together with the Leu215-His220 region, as being important for binding PDE4D5, but not PDE4D3. Transfection with wild-type beta-arrestin 2 profoundly decreased isoprenaline-stimulated PKA phosphorylation of the beta2-AR in MEFs (mouse embryo fibroblasts) lacking both beta-arrestin 1 and beta-arrestin 2. This effect was negated using either the R26A or the R286A mutant form of beta-arrestin 2 or a mutant with substitution of an alanine cassette for Leu215-His220, which showed little or no PDE4D5 binding, but was still recruited to the beta2-AR upon isoprenaline challenge. These data show that the interaction of PDE4D5 with both the N- and C-domains of beta-arrestin 2 are essential for beta2-AR regulation.
β2肾上腺素能受体(β2 - adrenoceptors)在胞质β - arrestin募集后会迅速脱敏。磷酸二酯酶4D5(4型环磷酸腺苷特异性磷酸二酯酶,D亚家族,同工型5)可与β - arrestin形成复合物被募集,随后它调节β2肾上腺素能受体的蛋白激酶A(cAMP依赖性蛋白激酶)磷酸化。在本研究中,我们使用了新技术,采用固定在纤维素膜上的重叠肽(25肽)文库来扫描β - arrestin 2的整个序列,以确定β - arrestin 2上与磷酸二酯酶4D5及同源长同工型磷酸二酯酶4D3结合的相互作用位点。我们在β - arrestin 2的N结构域中确定了一个用于常见磷酸二酯酶4D催化单元的结合位点,以及β - arrestin 2的C结构域中赋予磷酸二酯酶4D5结合特异性的两个区域。对N结构域结合区域的丙氨酸扫描肽阵列分析表明,R26A取代后与磷酸二酯酶4D5的相互作用严重降低,K18A或T20A取代后相互作用减弱。对β - arrestin 2的C结构域进行类似分析发现,Arg286和Asp291以及Leu215 - His220区域对于结合磷酸二酯酶4D5很重要,但对磷酸二酯酶4D3不重要。在缺乏β - arrestin 1和β - arrestin 2的小鼠胚胎成纤维细胞(MEFs)中,用野生型β - arrestin 2转染可显著降低异丙肾上腺素刺激的β2肾上腺素能受体的蛋白激酶A磷酸化。使用β - arrestin 2的R26A或R286A突变形式或用丙氨酸盒取代Leu215 - His220的突变体可消除这种作用,这些突变体几乎没有或没有磷酸二酯酶4D5结合,但在异丙肾上腺素刺激后仍被募集到β2肾上腺素能受体上。这些数据表明,磷酸二酯酶4D5与β - arrestin 2的N和C结构域的相互作用对于β2肾上腺素能受体的调节至关重要。